Rujukan APICA (ubat kanabinoid sintetik)

  1. ↑ "Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice" (PDF). Forensic Science International. 265: 6–12. August 2016. doi:10.1016/j.forsciint.2015.12.035. PMID 26826846.Selenggaraan CS1: display-pengarang (link)
  2. ↑ "Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products". Forensic Toxicology. 30 (2): 114–125. 2012. doi:10.1007/s11419-012-0136-7.
  3. ↑ "URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products". Forensic Science International. 227 (1–3): 21–32. April 2013. doi:10.1016/j.forsciint.2012.08.047. PMID 23063179.
  4. ↑ "The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse". ACS Chemical Neuroscience. 4 (7): 1081–92. July 2013. doi:10.1021/cn400035r. PMC 3715837. PMID 23551277.Selenggaraan CS1: display-pengarang (link)
  5. ↑ "Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135". ACS Chemical Neuroscience. 6 (8): 1445–58. August 2015. doi:10.1021/acschemneuro.5b00107. PMID 25921407.Selenggaraan CS1: display-pengarang (link)
  6. ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (dalam bahasa Chinese). China Food and Drug Administration. 27 September 2015. Dicapai pada 1 October 2015.Selenggaraan CS1: bahasa tidak dikenali (link)